Single mutation in peptide inhibitor of TRPV1 receptor changes its effect from hypothermic to hyperthermic level in animals


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The TRPV1 receptor plays a significant role in many biological processes, such as perception of external temperature (above 43°C), inflammation development, and thermoregulation. Activation of TRPV1 leads to the pain occurrence and decrease in the body temperature, while inhibition of this receptor can lead to an increase in the temperature. The TRPV1 peptide modulators from sea anemone Heteractis crispa extract (APHC1 and APHC3) have been previously characterized as molecules, which generated a pronounced analgesic effect and a decrease in the body temperature in experimental animals. Using the combined APHC1 and APHC3 amino acid sequences, we have prepared a hybrid peptide molecule named A13 that contains all residues potentially important for the activity of the peptide precursors. Biological tests on animals have shown that the hybrid molecule not only combines the analgesic properties of both peptides but, unlike the peptide precursors, also raises the body temperature of experimental animals.

About the authors

I. A. Dyachenko

Branch of the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pushchino State Institute of Natural Science; Pushchino Scientific Center of the Russian Academy of Sciences

Email: serg@ibch.ru
Russian Federation, Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290

V. A. Palikov

Branch of the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pushchino State Institute of Natural Science

Email: serg@ibch.ru
Russian Federation, Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290

Yu. A. Palikova

Branch of the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pushchino State Institute of Natural Science

Email: serg@ibch.ru
Russian Federation, Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290

G. I. Belous

Branch of the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pushchino State Institute of Natural Science

Email: serg@ibch.ru
Russian Federation, Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290

A. N. Murashev

Branch of the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pushchino State Institute of Natural Science; Pushchino Scientific Center of the Russian Academy of Sciences

Email: serg@ibch.ru
Russian Federation, Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290

Ya. A. Andreev

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Sechenov First Moscow State Medical University, Institute of Molecular Medicine; Russian University of Peoples’ Friendship

Email: serg@ibch.ru
Russian Federation, Moscow, 117997; Moscow, 119991; Moscow, 117198

Yu. A. Logashina

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Sechenov First Moscow State Medical University, Institute of Molecular Medicine

Email: serg@ibch.ru
Russian Federation, Moscow, 117997; Moscow, 119991

E. E. Maleeva

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: serg@ibch.ru
Russian Federation, Moscow, 117997

E. V. Grishin

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: serg@ibch.ru
Russian Federation, Moscow, 117997

S. A. Kozlov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Author for correspondence.
Email: serg@ibch.ru
Russian Federation, Moscow, 117997


Copyright (c) 2017 Pleiades Publishing, Ltd.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies